Cargando…
Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves’ disease
Antithyroid drugs are generally selected as the first-line treatment for Graves’ Disease (GD); however, the existence of patients showing resistance or severe side effects to these drugs is an important issue to be solved. The (pro)renin receptor [(P)RR] is a multi-functional protein that activates...
Autores principales: | Mizuguchi, Yuki, Morimoto, Satoshi, Kimura, Shihori, Takano, Noriyoshi, Yamashita, Kaoru, Seki, Yasufumi, Bokuda, Kanako, Yatabe, Midori, Yatabe, Junichi, Watanabe, Daisuke, Ando, Takashi, Ichihara, Atsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886569/ https://www.ncbi.nlm.nih.gov/pubmed/29621332 http://dx.doi.org/10.1371/journal.pone.0195464 |
Ejemplares similares
-
Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
por: Seki, Yasufumi, et al.
Publicado: (2023) -
Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves’ Disease: A Retrospective Cohort Study
por: Yamashita, Kaoru, et al.
Publicado: (2021) -
Elevated (Pro)renin Receptor Expression Contributes to Maintaining Aerobic Metabolism in Growth Hormone Deficiency
por: Seki, Yasufumi, et al.
Publicado: (2018) -
Buffering roles of (pro)renin receptor in starvation‐induced autophagy of skeletal muscles
por: Mizuguchi, Yuki, et al.
Publicado: (2018) -
Effect of Pretransplant Use of Calcimimetic on Parathyroid Function after Renal Transplantation
por: Bokuda, Kanako, et al.
Publicado: (2021)